Table 1 Patient characteristics on admission
Variables | Data |
|---|---|
Male, n (%) | 18 (72.0%) |
Mean age, years | 66.8±9.5 |
Primary tumors | |
Colonic cancer | 12 (48.0%) |
Rectal cancer | 5 (20.0%) |
Gastric cancer | 5 (20.0%) |
Duodenal cancer | 3 (12.0%) |
Median duration of symptom | 4.0 (0.5, 11.0) |
Previous resection for primary tumors | 17 (68.0%) |
Radiotherapy and/or chemotherapy | 16 (64.0%) |
Targeted therapy and/or immunotherapy | 14 (56.0%) |
Single/multiple intrahepatic metastases | 6 (24.0%)/19 (76.0%) |
Child-Pugh stage of A/B | 20 (80.0%)/5 (20.0%) |
Right/left/whole liver | 7 (28.0%)/2 (8.0%)/16 (64.0%) |
Tumor diameter, mm | 81.1±36.7 |
Pre-operative laboratory tests | |
WBC, normal 4–10×109/L | 5.0 (3.5, 6.5) |
AFP, normal 0–10 ng/mL | 3.0 (2.4, 3.7) |
CEA, normal 0–4 ng/mL | 62.8 (6.5, 228.1) |
CA125, normal 0–35 U/mL | 29.6 (12.9, 66.6) |
CA153, normal 0–30 U/mL | 9.7 (8.0, 17.5) |
CA19-9, normal 0–37 U/mL | 79.2 (22.5, 183.5) |
Ki67, % | 70.0 (50.0, 80.0) |
TAP, normal 0–121 | 150.5 (145.2, 182.5) |